(VIANEWS) – Equus Total Return (EQS), Corcept Therapeutics Incorporated (CORT), Summit Financial Group (SMMF) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Equus Total Return (EQS)
139.2% sales growth and 26.15% return on equity
Equus Total Return, Inc. is a business development company (BDC) specializing in leveraged buyouts, management buyouts, corporate partnerships/joint ventures, growth and expansion capital, acquisition financing, roll-up acquisition strategies, operational turnarounds, recapitalizations of existing businesses, special situations, equity and equity-oriented securities issued by privately owned companies, debt securities including subordinate debt, debt convertible into common or preferred stock, or debt combined with warrants and common and preferred stock, and preferred equity financing. It invests in small to mid-sized companies and acts as a lead investor. It invests in technology, telecommunication, financial services, natural resource and industrial manufacturing and services. It invests in companies engaged in the alternative energy, real estate, healthcare, education, e-learning, leisure and entertainment, and foreign investment sector in the United States, China, India, and Europe. It investments include common and preferred stock, debt convertible into common or preferred stock, debt combined with warrants and options, and other rights to acquire common or preferred stock. It seeks to invest in companies between $1 million to $25 million with revenues between $5 million and $150 million with EBITDA between $2 million to $50 million. It seeks to take control and non-control equity positions. Equus Total Return, Inc. was founded in 1991 and is based in Houston, Texas with additional office in Vancouver, Canada.
Earnings Per Share
As for profitability, Equus Total Return has a trailing twelve months EPS of $0.81.
PE Ratio
Equus Total Return has a trailing twelve months price to earnings ratio of 1.81. Meaning, the purchaser of the share is investing $1.81 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.15%.
Moving Average
Equus Total Return’s value is higher than its 50-day moving average of $1.47 and under its 200-day moving average of $1.52.
Yearly Top and Bottom Value
Equus Total Return’s stock is valued at $1.47 at 00:22 EST, way under its 52-week high of $1.75 and way higher than its 52-week low of $1.32.
2. Corcept Therapeutics Incorporated (CORT)
21.6% sales growth and 19.55% return on equity
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with serous ovarian tumors, as well as in Phase III clinical trial for the treatment of solid tumors. The company is also developing selective cortisol modulator combined with Xtandi that is in open label dose finding trial to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Earnings Per Share
As for profitability, Corcept Therapeutics Incorporated has a trailing twelve months EPS of $0.8.
PE Ratio
Corcept Therapeutics Incorporated has a trailing twelve months price to earnings ratio of 33.42. Meaning, the purchaser of the share is investing $33.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.55%.
3. Summit Financial Group (SMMF)
19.3% sales growth and 14.17% return on equity
Summit Financial Group, Inc. operates as a financial holding company for Summit Community Bank, Inc. that provides community banking and other financial services to individuals and businesses primarily in the Eastern Panhandle, Southern and North Central regions of West Virginia and the Northern, and Shenandoah Valley and Southwestern regions of Virginia, and the Central region of Kentucky. The company's community banking services include demand, savings, and time deposits; commercial, commercial real estate, construction and land development, residential real estate, and consumer loans; and mortgage warehouse lines of credit, as well as trust and wealth management, cash management, and insurance brokerage services. As of December 31, 2020, it operated through 43 banking offices. The company was incorporated in 1987 and is headquartered in Moorefield, West Virginia.
Earnings Per Share
As for profitability, Summit Financial Group has a trailing twelve months EPS of $3.85.
PE Ratio
Summit Financial Group has a trailing twelve months price to earnings ratio of 6.93. Meaning, the purchaser of the share is investing $6.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.17%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 5.2% and a negative 0.9%, respectively.
Sales Growth
Summit Financial Group’s sales growth is 20.7% for the ongoing quarter and 19.3% for the next.
4. StoneCo (STNE)
14.1% sales growth and 7.6% return on equity
StoneCo Ltd. provides financial technology and software solutions to merchants and integrated partners to conduct electronic commerce across in-store, online, and mobile channels in Brazil. It distributes its solutions, principally through proprietary Stone Hubs, which offer hyper-local sales and services; and sells solutions to brick-and-mortar and digital merchants through sales team. The company served approximately 2.6 million clients primarily small-and-medium-sized businesses; and marketplaces, e-commerce platforms, and integrated software vendors. StoneCo Ltd. was founded in 2000 and is headquartered in George Town, the Cayman Islands.
Earnings Per Share
As for profitability, StoneCo has a trailing twelve months EPS of $0.63.
PE Ratio
StoneCo has a trailing twelve months price to earnings ratio of 27.13. Meaning, the purchaser of the share is investing $27.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.6%.
Previous days news about StoneCo(STNE)
- Brokers suggest investing in stoneco ltd. (stne): read this before placing a bet. According to Zacks on Wednesday, 13 December, "Looking at the earnings estimate revisions for StoneCo Ltd., the Zacks Consensus Estimate for the current year has increased 7.9% over the past month to $0.85.", "Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let’s see what these Wall Street heavyweights think about StoneCo Ltd. "
5. Solar Capital Ltd. (SLRC)
11.5% sales growth and 7.21% return on equity
Solar Capital Ltd. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate sctivities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools. The fund primarily invests in United States. The fund's investments generally range between $5 million and $100 million. The fund invests in companies with revenues between $50 million and $1 billion and EBITDA between $15 million and $100 million. It invests in the form of senior secured loans, mezzanine loans, and equity securities. It may also seek investments in thinly traded public companies and also make secondary investments. The fund makes non-control equity investments. It primarily exits within three years of the initial capital commitment.
Earnings Per Share
As for profitability, Solar Capital Ltd. has a trailing twelve months EPS of $1.33.
PE Ratio
Solar Capital Ltd. has a trailing twelve months price to earnings ratio of 11.6. Meaning, the purchaser of the share is investing $11.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.21%.
6. Booz Allen Hamilton Holding Corporation (BAH)
7.7% sales growth and 25.71% return on equity
Booz Allen Hamilton Holding Corporation provides management and technology consulting, analytics, engineering, digital, mission operations, and cyber solutions to governments, corporations, and not-for-profit organizations in the United States and internationally. The company offers consulting solutions for various domains, business strategies, human capital, and operations. It also provides analytics services, which focuses on delivering transformational solutions in the areas of artificial intelligence, such as machine learning, deep learning; data science, such as data engineering and predictive modeling; automation and decision analytics; and quantum computing. In addition, the company designs, develops, and implements solutions built on contemporary methodologies and modern architectures; delivers engineering services and solutions to define, develop, implement, sustain, and modernize complex physical systems; and provides cyber risk management solutions, such as prevention, detection, and cost effectiveness. Booz Allen Hamilton Holding Corporation was founded in 1914 and is headquartered in McLean, Virginia.
Earnings Per Share
As for profitability, Booz Allen Hamilton Holding Corporation has a trailing twelve months EPS of $2.23.
PE Ratio
Booz Allen Hamilton Holding Corporation has a trailing twelve months price to earnings ratio of 56.11. Meaning, the purchaser of the share is investing $56.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.71%.
7. WillScot Mobile Mini Holdings Corp. (WSC)
5.9% sales growth and 23.68% return on equity
WillScot Mobile Mini Holdings Corp. provides modular space and portable storage solutions in the United States, Canada, Mexico, and the United Kingdom. The company leases various office space and storage solutions for temporary applications across a customer base in the commercial and industrial, construction, retail, education, health care, government, transportation, security, and energy sectors. . It operates a fleet of over 350,000 portable offices and storage containers. The company is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, WillScot Mobile Mini Holdings Corp. has a trailing twelve months EPS of $1.71.
PE Ratio
WillScot Mobile Mini Holdings Corp. has a trailing twelve months price to earnings ratio of 24.49. Meaning, the purchaser of the share is investing $24.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.68%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.6%, now sitting on 2.34B for the twelve trailing months.
Volume
Today’s last reported volume for WillScot Mobile Mini Holdings Corp. is 2064290 which is 14.91% above its average volume of 1796320.
Yearly Top and Bottom Value
WillScot Mobile Mini Holdings Corp.’s stock is valued at $41.87 at 00:22 EST, way below its 52-week high of $53.46 and way higher than its 52-week low of $34.40.
Earnings Before Interest, Taxes, Depreciation, and Amortization
WillScot Mobile Mini Holdings Corp.’s EBITDA is 4.89.
8. The Joint Corp. (JYNT)
5.8% sales growth and 6.15% return on equity
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of January 27, 2021, the company operated approximately 550 locations in the United States. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Earnings Per Share
As for profitability, The Joint Corp. has a trailing twelve months EPS of $0.18.
PE Ratio
The Joint Corp. has a trailing twelve months price to earnings ratio of 52.5. Meaning, the purchaser of the share is investing $52.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.15%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
The Joint Corp.’s EBITDA is 1.28.
